SHARE
Pharmaceutical Drug Delivery Market

Pharmaceutical Drug Delivery Market Forecasts to 2028 – Global Analysis By Route of Administration (Injectable, Oral), Application (Cancer, Diabetes), End User (Hospitals, Diagnostic Centers) and By Geography

4.1 (98 reviews)
Published: July 2021 ID: SMRC20763
4.1 (98 reviews)
Published: July 2021 ID: SMRC20763

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Pharmaceutical Drug Delivery Market is accounted for $1,430.50 billion in 2020 and is expected to reach $2,871.35 billion by 2028 growing at a CAGR of 9.1% during the forecast period. Factors such as rise in healthcare expenditure, growing concern and awareness about healthcare, and government support for research in the field of drug delivery are driving the growth of the market. However, risk of needlestick injuries is hampering the growth of the market.

A pharmaceutical drug delivery is a formulation or a device, which is employed for the administration of a therapeutic substance into the body. It functions by deploying medications to specifically targeted parts of the body by the aid of a medium, which can control the administration of the therapy by the means of either a physiological or chemical trigger. It is used to improve the efficacy and safety of an administered drug by controlling the rate, time, and site of release of drug in the body.

Based on the route of administration, the injectable drug delivery segment is anticipated to expand at a rapid pace during the forecast period owing to the increasing prevalence of chronic diseases, growing demand for biosimilar products, and low cost of devices. By geography, North America is going to have high growth during the forecast period which can be attributed to the increasing patient compliance to innovative drug delivery technologies and the presence of a large number of prominent players in this region.

Some of the key players profiled in the Pharmaceutical Drug Delivery Market include Teva Pharmaceuticals, Sanofi, Pfizer, Inc., Bristol-Myers Squibb, Novartis AG , Merck & Co., Inc., Becton, Amgen, F. Hoffman-La Roche, Eli Lilly and Company, Dickinson and Company, Antares Pharma, Inc, Boehringer Ingelheim, Johnson & Johnson, Inc., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Genmab A/S, AbbVie, 3M Company, and Gilead Sciences, Inc.

Report Coverage

Details

Published Year:

2021

Estimated Market Size in 2020:

USD 1,430.50 billion

Estimated Period:

2020

Compound Annual Growth Rate (CAGR) from 2020 to 2028:

9.1%

Predicted 2028 Value:

USD 2,871.35 billion

Forecast Years:

2021-2028

Tables, Graphs& Figures

298

Chapters Covered:

Route of Administration, Application, End User and Region

Core Drivers and Opportunities:

  • Rise in healthcare expenditure
  • Growing concern and awareness about healthcare
  • Increasing demand for biosimilars

Restraining Factors & Market Threats:

  • Risk of needle stick injuries
  • Rising incidences of drug failures


Routes of Administration Covered:
• Injectable Drug Delivery
• Oral Drug Delivery
• Ocular Drug Delivery
• Topical Drug Delivery
• Nasal Drug Delivery
• Pulmonary Drug Delivery
• Implantable Drug Delivery
• Transmucosal Drug Delivery

Applications Covered:
• Cardiovascular Diseases
• Respiratory Diseases
• Cancer
• Infectious Diseases
• Diabetes
• Central Nervous System Disorders
• Autoimmune Diseases
• Other Applications    

End Users Covered:
• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers/Clinics
• Home Care Settings 

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Key Questions Answered In The Report

The Global Pharmaceutical Drug Delivery Market is majorly driven by rise in healthcare expenditure, growing concern and awareness about healthcare, and government support for research in the field of drug delivery.

The injectable drug delivery segment is growing at a highest CAGR owing to the increasing prevalence of chronic diseases and growing demand for biosimilar products.

North America dominated with a significant market share due to the presence of a large number of prominent players in this region.

Asia Pacific market is growing at a highest CAGR owing to the rising awareness regarding the use of pharmaceutical drug delivery in the region.

Key players in Pharmaceutical Drug Delivery Market include Teva Pharmaceuticals, Sanofi, Pfizer, Inc., Bristol-Myers Squibb, Novartis AG , Merck & Co., Inc., Becton, Amgen, F. Hoffman-La Roche, Eli Lilly and Company, Dickinson and Company, Antares Pharma, Inc, Boehringer Ingelheim, Johnson & Johnson, Inc., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Genmab A/S, AbbVie, 3M Company, and Gilead Sciences, Inc.

1 Executive Summary      
        
2 Preface    
   
 2.1 Abstract      
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology    
  2.4.1 Data Mining    
  2.4.2 Data Analysis    
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions    
        
3 Market Trend Analysis     
 3.1 Introduction     
 3.2 Drivers      
 3.3 Restraints      
 3.4 Opportunities     
 3.5 Threats      
 3.6 Application Analysis     
 3.7 End User Analysis     
 3.8 Emerging Markets     
 3.9 Impact of Covid-19     
        
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes      
 4.4 Threat of new entrants    
 4.5 Competitive rivalry     
        
5 Global Pharmaceutical Drug Delivery Market, By Route of Administration 
 5.1 Introduction     
 5.2 Injectable Drug Delivery    
  5.2.1 Self-Injection Devices   
   5.2.1.1 Wearable Injectors   
   5.2.1.2 Pen Injectors   
   5.2.1.3 Needle-Free Injectors  
   5.2.1.4 Autoinjectors   
  5.2.2 Conventional Injection Devices   
   5.2.2.1 Product    
    5.2.2.1.1 Prefilled Syringes  
    5.2.2.1.2 Fillable Syringes  
   5.2.2.2 Usability    
    5.2.2.2.1 Disposable Syringes  
    5.2.2.2.2 Reusable Syringes  
   5.2.2.3 Material    
    5.2.2.3.1 Plastic   
    5.2.2.3.2 Glass   
 5.3 Oral Drug Delivery     
  5.3.1 Liquid Oral Drugs    
   5.3.1.1 Solutions     
   5.3.1.2 Syrups    
  5.3.2 Semi-Solid Oral Drugs   
   5.3.2.1 Elixirs    
   5.3.2.2 Emulsions    
   5.3.2.3 Gels    
  5.3.3 Solid Oral Drugs    
   5.3.3.1 Tablets    
   5.3.3.2 Powders    
   5.3.3.3 Pills    
   5.3.3.4 Capsules    
 5.4 Ocular Drug Delivery     
  5.4.1 Ocular Semi-Solid Formulations   
   5.4.1.1 Eye Ointments   
   5.4.1.2 Gels    
  5.4.2 Ocular Ocular Devices   
   5.4.2.1 Ocular Inserts   
   5.4.2.2 Drug-Coated Contact Lenses  
  5.4.3 Ocular Liquid Formulations   
   5.4.3.1 Liquid Sprays   
   5.4.3.2 Eye Drops    
 5.5 Topical Drug Delivery    
  5.5.1 Topical Liquid Formulations   
   5.5.1.1 Suspensions   
   5.5.1.2 Solutions    
  5.5.2 Topical Transdermal Products   
   5.5.2.1 Transdermal Gels   
   5.5.2.2 Transdermal Patches   
  5.5.3 Topical Semi-Solid Formulations   
   5.5.3.1 Pastes    
   5.5.3.2 Ointments   
   5.5.3.3 Lotions    
   5.5.3.4 Gels    
   5.5.3.5 Creams    
  5.5.4 Topical Solid Formulations   
   5.5.4.1 Powders    
   5.5.4.2 Suppositories   
 5.6 Nasal Drug Delivery     
  5.6.1 Nasal Sprays    
  5.6.2 Nasal Powders    
  5.6.3 Nasal Gels    
  5.6.4 Nasal Drops    
 5.7 Pulmonary Drug Delivery    
  5.7.1 Dry Powder Inhaler    
  5.7.2 Metered-Dose Inhaler   
  5.7.3 Nebulizers    
   5.7.3.1 Ultrasonic Nebulizers  
   5.7.3.2 Soft Mist Nebulizers   
   5.7.3.3 Jet Nebulizers   
 5.8 Implantable Drug Delivery    
  5.8.1 Passive Implantable Drug Delivery  
  5.8.2 Active Implantable Drug Delivery  
 5.9 Transmucosal Drug Delivery    
  5.9.1 Oral Formulations    
   5.9.1.1 Sublingual Drug Delivery  
   5.9.1.2 Buccal Drug Delivery   
  5.9.2 Other Transmucosal Drug Delivery Technologies 
   5.9.2.1 Vaginal Transmucosal Drug Delivery 
   5.9.2.2 Rectal Transmucosal Drug Delivery 
        
6 Global Pharmaceutical Drug Delivery Market, By Application   
 6.1 Introduction     
 6.2 Cardiovascular Diseases    
 6.3 Respiratory Diseases     
 6.4 Cancer      
 6.5 Infectious Diseases     
 6.6 Diabetes      
 6.7 Central Nervous System Disorders   
 6.8 Autoimmune Diseases    
 6.9 Other Applications     
  6.9.1 Endocrine Disorders    
  6.9.2 Ophthalmic Disorders   
        
7 Global Pharmaceutical Drug Delivery Market, By End User  

 7.1 Introduction     
 7.2 Hospitals      
 7.3 Diagnostic Centers     
 7.4 Ambulatory Surgery Centers/Clinics   
 7.5 Home Care Settings     
        
8 Global Pharmaceutical Drug Delivery Market, By Geography  
 8.1 Introduction      
 8.2 North America     
  8.2.1 US     
  8.2.2 Canada     
  8.2.3 Mexico     
 8.3 Europe      
  8.3.1 Germany     
  8.3.2 UK     
  8.3.3 Italy     
  8.3.4 France     
  8.3.5 Spain     
  8.3.6 Rest of Europe    
 8.4 Asia Pacific      
  8.4.1 Japan     
  8.4.2 China     
  8.4.3 India     
  8.4.4 Australia     
  8.4.5 New Zealand    
  8.4.6 South Korea    
  8.4.7 Rest of Asia Pacific    
 8.5 South America     
  8.5.1 Argentina     
  8.5.2 Brazil     
  8.5.3 Chile      
  8.5.4 Rest of South America   
 8.6 Middle East & Africa     
  8.6.1 Saudi Arabia    
  8.6.2 UAE     
  8.6.3 Qatar     
  8.6.4 South Africa    
  8.6.5 Rest of Middle East & Africa   
        
9 Key Developments      
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures 
 9.2 Acquisitions & Mergers    
 9.3 New Product Launch     
 9.4 Expansions     
 9.5 Other Key Strategies     
        
10 Company Profiling      

 10.1 Teva Pharmaceuticals    
 10.2 Sanofi       
 10.3 Pfizer, Inc.     
 10.4 Bristol-Myers Squibb     
 10.5 Novartis AG     
 10.6 Merck & Co., Inc.     
 10.7 Becton      
 10.8 Amgen       
 10.9 F. Hoffman-La Roche     
 10.10 Eli Lilly and Company     
 10.11 Dickinson and Company    
 10.12 Antares Pharma, Inc     
 10.13 Boehringer Ingelheim    
 10.14 Johnson & Johnson, Inc.    
 10.15 GlaxoSmithKline plc     
 10.16 Bayer AG      
 10.17 AstraZeneca      
 10.18 Genmab A/S      
 10.19 AbbVie       
 10.20 3M Company     
 10.21 Gilead Sciences, Inc.     


List of Tables       
1 Global Pharmaceutical Drug Delivery Market Outlook, By Region (2019-2028) ($MN)
2 Global Pharmaceutical Drug Delivery Market Outlook, By Route of Administration (2019-2028) ($MN)
3 Global Pharmaceutical Drug Delivery Market Outlook, By Injectable Drug Delivery (2019-2028) ($MN)
4 Global Pharmaceutical Drug Delivery Market Outlook, By Self-Injection Devices (2019-2028) ($MN)
5 Global Pharmaceutical Drug Delivery Market Outlook, By Conventional Injection Devices (2019-2028) ($MN)
6 Global Pharmaceutical Drug Delivery Market Outlook, By Oral Drug Delivery (2019-2028) ($MN)
7 Global Pharmaceutical Drug Delivery Market Outlook, By Liquid Oral Drugs (2019-2028) ($MN)
8 Global Pharmaceutical Drug Delivery Market Outlook, By Semi-Solid Oral Drugs (2019-2028) ($MN)
9 Global Pharmaceutical Drug Delivery Market Outlook, By Solid Oral Drugs (2019-2028) ($MN)
10 Global Pharmaceutical Drug Delivery Market Outlook, By Ocular Drug Delivery (2019-2028) ($MN)
11 Global Pharmaceutical Drug Delivery Market Outlook, By Ocular Semi-Solid Formulations (2019-2028) ($MN)
12 Global Pharmaceutical Drug Delivery Market Outlook, By Ocular Ocular Devices (2019-2028) ($MN)
13 Global Pharmaceutical Drug Delivery Market Outlook, By Ocular Liquid Formulations (2019-2028) ($MN)
14 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Drug Delivery (2019-2028) ($MN)
15 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Liquid Formulations (2019-2028) ($MN)
16 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Transdermal Products (2019-2028) ($MN)
17 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Semi-Solid Formulations (2019-2028) ($MN)
18 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Solid Formulations (2019-2028) ($MN)
19 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Drug Delivery (2019-2028) ($MN)
20 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Sprays (2019-2028) ($MN)
21 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Powders (2019-2028) ($MN)
22 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Gels (2019-2028) ($MN)
23 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Drops (2019-2028) ($MN)
24 Global Pharmaceutical Drug Delivery Market Outlook, By Pulmonary Drug Delivery (2019-2028) ($MN)
25 Global Pharmaceutical Drug Delivery Market Outlook, By Dry Powder Inhaler (2019-2028) ($MN)
26 Global Pharmaceutical Drug Delivery Market Outlook, By Metered-Dose Inhaler (2019-2028) ($MN)
27 Global Pharmaceutical Drug Delivery Market Outlook, By Nebulizers (2019-2028) ($MN)
28 Global Pharmaceutical Drug Delivery Market Outlook, By Implantable Drug Delivery (2019-2028) ($MN)
29 Global Pharmaceutical Drug Delivery Market Outlook, By Passive Implantable Drug Delivery (2019-2028) ($MN)
30 Global Pharmaceutical Drug Delivery Market Outlook, By Active Implantable Drug Delivery (2019-2028) ($MN)
31 Global Pharmaceutical Drug Delivery Market Outlook, By Transmucosal Drug Delivery (2019-2028) ($MN)
32 Global Pharmaceutical Drug Delivery Market Outlook, By Oral Formulations (2019-2028) ($MN)
33 Global Pharmaceutical Drug Delivery Market Outlook, By Other Transmucosal Drug Delivery Technologies (2019-2028) ($MN)
34 Global Pharmaceutical Drug Delivery Market Outlook, By Application (2019-2028) ($MN)
35 Global Pharmaceutical Drug Delivery Market Outlook, By Cardiovascular Diseases (2019-2028) ($MN)
36 Global Pharmaceutical Drug Delivery Market Outlook, By Respiratory Diseases (2019-2028) ($MN)
37 Global Pharmaceutical Drug Delivery Market Outlook, By Cancer (2019-2028) ($MN)
38 Global Pharmaceutical Drug Delivery Market Outlook, By Infectious Diseases (2019-2028) ($MN)
39 Global Pharmaceutical Drug Delivery Market Outlook, By Diabetes (2019-2028) ($MN)
40 Global Pharmaceutical Drug Delivery Market Outlook, By Central Nervous System Disorders (2019-2028) ($MN)
41 Global Pharmaceutical Drug Delivery Market Outlook, By Autoimmune Diseases (2019-2028) ($MN)
42 Global Pharmaceutical Drug Delivery Market Outlook, By Other Applications (2019-2028) ($MN)
43 Global Pharmaceutical Drug Delivery Market Outlook, By Endocrine Disorders (2019-2028) ($MN)
44 Global Pharmaceutical Drug Delivery Market Outlook, By Ophthalmic Disorders (2019-2028) ($MN)
45 Global Pharmaceutical Drug Delivery Market Outlook, By End User (2019-2028) ($MN)
46 Global Pharmaceutical Drug Delivery Market Outlook, By Hospitals (2019-2028) ($MN)
47 Global Pharmaceutical Drug Delivery Market Outlook, By Diagnostic Centers (2019-2028) ($MN)
48 Global Pharmaceutical Drug Delivery Market Outlook, By Ambulatory Surgery Centers/Clinics (2019-2028) ($MN)
49 Global Pharmaceutical Drug Delivery Market Outlook, By Home Care Settings (2019-2028) ($MN)
        
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials